A citation-based method for searching scientific literature

J William Langston. J Parkinsons Dis 2017
Times Cited: 128







List of co-cited articles
1417 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
21

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
19

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
19

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
17

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
15

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
14

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
J A Obeso, M Stamelou, C G Goetz, W Poewe, A E Lang, D Weintraub, D Burn, G M Halliday, E Bezard, S Przedborski,[...]. Mov Disord 2017
268
14


MPTP mouse models of Parkinson's disease: an update.
Gloria E Meredith, David J Rademacher. J Parkinsons Dis 2011
218
13

Oxidative stress and cellular pathologies in Parkinson's disease.
Lesly Puspita, Sun Young Chung, Jae-Won Shim. Mol Brain 2017
158
12

Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
Enza Maria Valente, Patrick M Abou-Sleiman, Viviana Caputo, Miratul M K Muqit, Kirsten Harvey, Suzana Gispert, Zeeshan Ali, Domenico Del Turco, Anna Rita Bentivoglio, Daniel G Healy,[...]. Science 2004
11

Rotenone, paraquat, and Parkinson's disease.
Caroline M Tanner, Freya Kamel, G Webster Ross, Jane A Hoppin, Samuel M Goldman, Monica Korell, Connie Marras, Grace S Bhudhikanok, Meike Kasten, Anabel R Chade,[...]. Environ Health Perspect 2011
633
11

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
10

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
554
10


Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
9

Protocol for the MPTP mouse model of Parkinson's disease.
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
572
9

On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.
Nicolas Giguère, Samuel Burke Nanni, Louis-Eric Trudeau. Front Neurol 2018
94
9


Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Jin-Sung Park, Ryan L Davis, Carolyn M Sue. Curr Neurol Neurosci Rep 2018
168
9

Oxidative stress and Parkinson's disease.
Javier Blesa, Ines Trigo-Damas, Anna Quiroga-Varela, Vernice R Jackson-Lewis. Front Neuroanat 2015
368
8

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.
Derek Narendra, Atsushi Tanaka, Der-Fen Suen, Richard J Youle. J Cell Biol 2008
8

The genetics of Parkinson disease.
Hao Deng, Peng Wang, Joseph Jankovic. Ageing Res Rev 2018
195
8

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
Latha Devi, Vijayendran Raghavendran, Badanavalu M Prabhu, Narayan G Avadhani, Hindupur K Anandatheerthavarada. J Biol Chem 2008
628
8

Mitochondrial complex I deficiency in Parkinson's disease.
A H Schapira, J M Cooper, D Dexter, J B Clark, P Jenner, C D Marsden. J Neurochem 1990
8

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O'Brien, John Q Trojanowski, Virginia M-Y Lee. Science 2012
8

Selective neuronal vulnerability in Parkinson disease.
D James Surmeier, José A Obeso, Glenda M Halliday. Nat Rev Neurosci 2017
353
8

Mitochondrial dysfunction in Parkinson's disease.
Anindita Bose, M Flint Beal. J Neurochem 2016
307
8

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
579
8

alpha-Synuclein locus triplication causes Parkinson's disease.
A B Singleton, M Farrer, J Johnson, A Singleton, S Hague, J Kachergus, M Hulihan, T Peuralinna, A Dutra, R Nussbaum,[...]. Science 2003
8

Pathogenesis of Parkinson's disease.
Etienne C Hirsch, Peter Jenner, Serge Przedborski. Mov Disord 2013
159
8

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
Derek P Narendra, Seok Min Jin, Atsushi Tanaka, Der-Fen Suen, Clement A Gautier, Jie Shen, Mark R Cookson, Richard J Youle. PLoS Biol 2010
8

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Lena F Burbulla, Pingping Song, Joseph R Mazzulli, Enrico Zampese, Yvette C Wong, Sohee Jeon, David P Santos, Judith Blanz, Carolin D Obermaier, Chelsee Strojny,[...]. Science 2017
301
7

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
7

Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
7

Environmental toxins and Parkinson's disease.
Samuel M Goldman. Annu Rev Pharmacol Toxicol 2014
197
7

Exposure to pesticides or solvents and risk of Parkinson disease.
Gianni Pezzoli, Emanuele Cereda. Neurology 2013
143
7


alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
M G Spillantini, R A Crowther, R Jakes, M Hasegawa, M Goedert. Proc Natl Acad Sci U S A 1998
7

Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
Sudhakar Raja Subramaniam, Marie-Francoise Chesselet. Prog Neurobiol 2013
282
7

Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Maria Nguyen, Yvette C Wong, Daniel Ysselstein, Alex Severino, Dimitri Krainc. Trends Neurosci 2019
92
7


Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
441
7

Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.
Cornelis Blauwendraat, Karl Heilbron, Costanza L Vallerga, Sara Bandres-Ciga, Rainer von Coelln, Lasse Pihlstrøm, Javier Simón-Sánchez, Claudia Schulte, Manu Sharma, Lynne Krohn,[...]. Mov Disord 2019
107
7

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Jeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, Yaping Chu, Thomas G Beach, Charles H Adler, Glenda M Halliday, Raymond T Bartus. Brain 2013
573
7

The Emerging Evidence of the Parkinson Pandemic.
E Ray Dorsey, Todd Sherer, Michael S Okun, Bastiaan R Bloem. J Parkinsons Dis 2018
148
7

An essay on the shaking palsy. 1817.
James Parkinson. J Neuropsychiatry Clin Neurosci 2002
531
7

Glial reactions in Parkinson's disease.
Patrick L McGeer, Edith G McGeer. Mov Disord 2008
478
7

Genetics of Parkinson's disease.
Christine Klein, Ana Westenberger. Cold Spring Harb Perspect Med 2012
572
7

Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.